Related Experiment Video

Updated: Jul 17, 2026

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
12:02

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis

Published on: April 11, 2016

The use of the d-xylose excretion test in children

P A CLARK

    Gut
    |December 1, 1962
    PubMed

    Insights

    The modified d-xylose excretion test helps distinguish coeliac disease from pancreatic fibrocystic disease in children. This diagnostic tool aids in identifying specific gastrointestinal conditions affecting pediatric patients.

    Area of Science:

    • Pediatric Gastroenterology
    • Clinical Diagnostics

    Background:

    • Distinguishing coeliac disease from pancreatic fibrocystic disease in children presents diagnostic challenges.
    • Accurate differentiation is crucial for appropriate treatment and management.

    Purpose of the Study:

    • To evaluate the utility of a modified d-xylose excretion test for differentiating coeliac disease and pancreatic fibrocystic disease in pediatric patients.

    Main Methods:

    • The study utilized a modified d-xylose excretion test adapted for pediatric use.
    • The test's performance was assessed in differentiating between the two conditions.

    Main Results:

    • The modified d-xylose excretion test demonstrated value in differentiating coeliac disease from pancreatic fibrocystic disease.
    • Results indicate the test's effectiveness as a diagnostic aid in children.

    Conclusions:

    • The modified d-xylose excretion test is a valuable tool for pediatricians and gastroenterologists.
    • It aids in the differential diagnosis of malabsorption syndromes in children, specifically coeliac disease and pancreatic fibrocystic disease.

    Keywords:
    CELIAC DISEASEPANCREATIC CYSTIC FIBROSISXYLOSE

    More Related Videos

    Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo10:35

    Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

    Published on: April 6, 2022

    Bergmeyer Glucose Quantification for Microbiological Samples07:23

    Bergmeyer Glucose Quantification for Microbiological Samples

    Published on: January 17, 2025

    Related Concept Videos

    Glucose Transporters01:27

    Glucose Transporters

    Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
    Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...